← Scroll for more →
Financial Statements — WIMI
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1,313.98 | 1,959.99 | 1,070.51 | 502.71 | 47.75 | 58.73 | 572.78 | 705.62 | 117.93 |
| Short-term Investments | 2,062.82 | 1,229.64 | 117.96 | 92.51 | 435.66 | 43.40 | 38.45 | 84.50 | 150.90 |
| Accounts Receivable | 6.20 | 23.52 | 3.30 | 3.03 | 23.72 | 39.40 | 2.92 | 7.52 | 4.11 |
| Inventory | -- | -- | -- | -- | -- | 1.49 | 2.40 | 0.54 | 6.84 |
| Total Current Assets | 501.20 | 464.81 | 2,013.30 | 175.97 | 857.71 | 729.06 | 96.21 | 125.45 | 142.39 |
| Property, Plant & Equipment | 72.80 | 8.15 | 125.81 | 89.72 | 13.01 | 23.42 | 24.15 | 3.77 | 3.90 |
| Goodwill | -- | -- | -- | -- | -- | 243.33 | 34.94 | 41.53 | 276.98 |
| Intangible Assets | -- | -- | -- | -- | -- | 0.86 | 0.96 | 3.65 | 27.88 |
| Total Non-current Assets* | 85.38 | 9.95 | 19.34 | 171.60 | 173.30 | 78.16 | 1,164.13 | 1,361.50 | 93.67 |
| Total Assets | 3,608.22 | 3,398.61 | 299.42 | 200.05 | 145.57 | 182.30 | 1,260.34 | 1,486.95 | 236.06 |
| Accounts Payable | 35.10 | 24.09 | 3.87 | 23.39 | 4.26 | 44.92 | 3.63 | 30.86 | 4.39 |
| Short-term Debt | 30.00 | 4.19 | 2.09 | 17.85 | 1.91 | -- | -- | -- | -- |
| Total Current Liabilities | 131.03 | 132.69 | 103.52 | 532.76 | 32.96 | 15.93 | 109.08 | 129.40 | 91.76 |
| Total Non-current Liabilities* | 3.25 | 3.21 | 663.91 | 2.88 | 35.99 | 44.61 | 0.27 | 19.56 | 11.58 |
| Total Liabilities | 134.28 | 135.90 | 767.42 | 77.63 | 269.47 | 22.10 | 110.98 | 148.96 | 25.97 |
| Retained Earnings | (554.66) | (105.80) | (863.71) | (130.87) | (132.76) | (514.15) | (517.97) | (30.86) | (164.33) |
| Total Stockholder Equity | 2,208.91 | 207.03 | 999.18 | 105.21 | 106.31 | 148.92 | 150.97 | 1,264.52 | 198.26 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions CNY) (except per-share rows)| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|---|
| Total Revenue | 188.24 | -- | 290.82 | 38.27 | 64.71 |
| Cost of Revenue | 136.15 | -- | 203.24 | 264.76 | 64.71 |
| Gross Profit | 52.10 | -- | 12.29 | 80.98 | 84.28 |
| Research & Development | 4.68 | 0.00 | 75.82 | 13.33 | 10.43 |
| Selling, General & Admin | 36.24 | -- | 2.48 | 2.14 | 3.12 |
| Total Operating Expenses | 9.86 | -- | 12.75 | 16.18 | 14.58 |
| Operating Income | (18.49) | -- | (3.33) | (4.48) | (2.03) |
| Pretax Income | 128.56 | -- | 1.92 | (18.38) | (35.19) |
| Tax Provision | 2.29 | -- | 0.20 | 0.04 | (0.11) |
| Net Income | 106.30 | -- | 7.66 | (0.32) | (39.94) |
| Basic EPS | 10.32 | -- | -- | 0.00 | (0.23) |
| Diluted EPS | 4.54 | -- | 0.01 | 0.00 | (0.23) |
← Scroll for more columns →
Cash Flow Statement
(in billions CNY)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Operating Cash Flow | 0.21 | 0.15 | -0.00 | (0.01) |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow* | 0.21 | 0.15 | -0.00 | (0.01) |
| Investing Cash Flow | (0.05) | (0.22) | (0.17) | 0.00 |
| Financing Cash Flow | 1.05 | 0.29 | 0.02 | (0.07) |
← Scroll for more columns →
* Derived from reported values